Evidence map›Paper›PMID 36121299›Full record

ArticleJournal of virology2022

The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants.

Stacy Gellenoncourt, Nell Saunders, Rémy Robinot, Lucas Auguste, Maaran Michael Rajah, Jérôme Kervevan, Raphaël Jeger-Madiot, Isabelle Staropoli, Cyril Planchais, Hugo Mouquet and 3 more

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Stacy GellenoncourtVirus & Immunity Unit, Institut Pasteurgrid.428999.7, Université Paris Cité, CNRS UMR 3569, Paris, France.
Nell SaundersVirus & Immunity Unit, Institut Pasteurgrid.428999.7, Université Paris Cité, CNRS UMR 3569, Paris, France.
Rémy RobinotVirus & Immunity Unit, Institut Pasteurgrid.428999.7, Université Paris Cité, CNRS UMR 3569, Paris, France.
Lucas AugusteVirus & Immunity Unit, Institut Pasteurgrid.428999.7, Université Paris Cité, CNRS UMR 3569, Paris, France.
Maaran Michael RajahVirus & Immunity Unit, Institut Pasteurgrid.428999.7, Université Paris Cité, CNRS UMR 3569, Paris, France.
Jérôme KervevanVirus & Immunity Unit, Institut Pasteurgrid.428999.7, Université Paris Cité, CNRS UMR 3569, Paris, France.
Raphaël Jeger-MadiotVirus & Immunity Unit, Institut Pasteurgrid.428999.7, Université Paris Cité, CNRS UMR 3569, Paris, France.
Isabelle StaropoliVirus & Immunity Unit, Institut Pasteurgrid.428999.7, Université Paris Cité, CNRS UMR 3569, Paris, France.
Cyril PlanchaisLaboratory of Humoral Immunology, Institut Pasteurgrid.428999.7, Université Paris Cité, Paris, France.
Hugo MouquetLaboratory of Humoral Immunology, Institut Pasteurgrid.428999.7, Université Paris Cité, Paris, France.
Julian BuchrieserVirus & Immunity Unit, Institut Pasteurgrid.428999.7, Université Paris Cité, CNRS UMR 3569, Paris, France.
Olivier SchwartzVirus & Immunity Unit, Institut Pasteurgrid.428999.7, Université Paris Cité, CNRS UMR 3569, Paris, France.
Lisa A ChakrabartiVirus & Immunity Unit, Institut Pasteurgrid.428999.7, Université Paris Cité, CNRS UMR 3569, Paris, France.ORCID 0000-0002-1895-3630
Centre National de la Recherche Scientifique · FRInstitut Pasteur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remained genetically stable during the first 3 months of the pandemic, before acquiring a D614G spike mutation that rapidly spread worldwide and then generating successive waves of viral variants with increasingly high transmissibility. We set out to evaluate possible epistatic interactions between the early-occurring D614G mutation and the more recently emerged cleavage site mutations present in spike of the Alpha, Delta, and Omicron variants of concern. The P681H/R mutations at the S1/S2 cleavage site increased spike processing and fusogenicity but limited its incorporation into pseudoviruses. In addition, the higher cleavage rate led to higher shedding of the spike S1 subunit, resulting in a lower infectivity of the P681H/R-carrying pseudoviruses compared to those expressing the Wuhan wild-type spike. The D614G mutation increased spike expression at the cell surface and limited S1 shedding from pseudovirions. As a consequence, the D614G mutation preferentially increased the infectivity of P681H/R-carrying pseudoviruses. This enhancement was more marked in cells where the endosomal route predominated, suggesting that more stable spikes could better withstand the endosomal environment. Taken together, these findings suggest that the D614G mutation stabilized S1/S2 association and enabled the selection of mutations that increased S1/S2 cleavage, leading to the emergence of SARS-CoV-2 variants expressing highly fusogenic spikes.

Indexed as

COVID-19SARS-CoV-2Spike Glycoprotein, CoronavirusHumansMutationSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2epistasisproteolytic cleavageSARS-CoV-2spikevariants

Identifiers

PMID36121299
PMCPMC9555207
OpenAlexW4296330650

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.